Skip to main content

A phase IIa, randomized, parallel, double-blind, Placebo Controlled Study to Evaluate the Efficacy and safety of enpatoran in dermatomyositis and polymyositis participants receiving standard of care.

Open
  • Protocol code: MS200569_0041
  • EudraCT code: _
  • Research group: Systemic Diseases
  • Service: Internal Medicine
  • Principal investigator:  Selva O'Callaghan, Albert
  • Pathology: Símptomes, signes i troballes anormals clíniques i de laboratori, no classificades enlloc més
  • Phase: Fase II